+124.3%
GOOGL vs GSK
+64.8%
+59.4%
-30.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.1% | -1.2% | +3.3% | +2.2% |
| 7D | +1.6% | -1.1% | +2.6% | +1.6% |
| 30D | -16.8% | +7.8% | -24.6% | -17.0% |
| 3M | -14.6% | +0.3% | -14.9% | -14.6% |
| 6M | -24.4% | +3.4% | -27.8% | -24.5% |
| YTD | -6.1% | +5.9% | -12.0% | -5.9% |
| 1Y | +1.0% | +8.2% | -7.2% | +1.2% |
| All | +124.3% | +64.8% | +59.4% | +148.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling